(MENAFN- PR Newswire) DUBLIN, May 6, 2021 /PRNewswire/ -- The "2021 IVD Market Update and COVID-19 Impact" report has been added to ResearchAndMarkets.com's offering.
This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from the report's analysts to reflect the latest information.
Key Questions Answered:
- What is the Size of the IVD Market in 2021?
- What Impact has COVID-19 Had on IVD Markets?
- What Major Trends are Affecting the Market in 2021?
As part of its coverage, this report contains market sizing for the following categories of IVD:
- Clinical Chemistry
- Immunoassays- non isotopic
- Infectious disease
- Other immunos
- Blood bank screening
- Drugs of Abuse
- Diabetes HbA1c - lab
- Hematology - Core Lab
- Microbiology (ID/AST)
- Microbiology (molecular)
- Microbiology - Mass Spectrometry
- Radioimmunoassays
- Coagulation (PT/INR)
- Coagulation, molecular
- Histology/cytology
- HPV, molecular
- Nucleic acid assays
- Blood grouping/typing
- Blood bank molecular
- NAT Blood Screens
- Circulating tumor cells
- POC, OTC diabetes
- POC, OTC other
- POC, professional/hospital;
- COVID 19
Complete market figures and forecasts will be part of the Worldwide report in August.
How is COVID-19 Impacting the Market in 2021
This report does detail the effects of COVID-19 including the following:
- Effect of COVID-19 on Market Segments
- IVD Market excluding and with COVID-19, 2020
- IVD Market Distribution by Segment
- Global In Vitro Diagnostic Market - YoY Growth 2019-2020
- Global In Vitro Diagnostic Market - YoY Growth 2019-2020
- IVD Segment Performance, Q1 2020 - Q4 2020
- IVD Segment Performance, Total Market Value, 2020
Also included in this report:
- Product Trends and Developments
- COVID-19 Developments Sept. 2020 to Feb 2021
- Select IVD Market Participant Developments
- Competitive Leader Updates
Key Topics Covered:
ONE: WORLDWIDE IVD MARKET - 2020 UPDATE
COVID 19
IVD MARKET HIGHLIGHTS AND EFFECTS OF COVID-19
- Effect of COVID-19 on Market Segments
TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS
- NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS
- Clinical Chemistry
- Hematology
- Oncology
- Coagulation
- Immunoassay
- Microbiology
- Histology
- Molecular Specialties
- POC
- Mass Spectrometry
- COVID-19 DEVELOPMENTS - SEPTEMBER 2020 - FEBRUARY 2021
- Antigen
- Serology
- Molecular
THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS
- SELECTED COMPETITIVE LEADER UPDATES
- IVD Segment Growth by Leading Competitors, Change in Sales 2019-2020
- Changes in Market Distribution for IVD Sales, 2019-2020 - Roche Maintains Lead, Abbott Closing Gap
- Abbott
- Aidian Oy
- Becton Dickinson and Co
- Biomerieux SA
- Danaher
- Hologic, Inc.
- Illumina
- Ortho Clinical Diagnostics
- Perkin Elmer
- Quidel Corporation
- Roche Diagnostic
- Thermo Fisher Scientific
FOUR: NEW OPPORTUNITIES
- Telehealth and Remote Patient Monitoring
- Expanding Options in Reimbursement
- POC
For more information about this report visit
Media Contact:
Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
MENAFN06052021003732001241ID1102040749
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.